NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
M.D. Anderson Cancer Center
AHS Cancer Control Alberta
Icahn School of Medicine at Mount Sinai
University of Miami
Lund University Hospital
Lund University Hospital
All India Institute of Medical Sciences